Long-Term Persistence of Low Bone Density in Orthotopic Liver Transplantation
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
We determined bone density and metabolism in 46 patients (35 males, 11 females) who had undergone liver transplantation 1–48 months previously. Twenty-one patients were then followed for the next 24 months. At each visit, blood and urine samples for bone and liver metabolism parameters, as well as spinal and femoral dual-energy X-ray absorptiometry (DXA) scans, were obtained. Basal spinal and femoral density was low (p<0.001). Patients with pre-transplant cholestatic diseases had lower spinal density than all the other subjects (p<0.05) and the cumulative methylprednisolone intake was an independent negative predictor of total hip density (p<0.02). At baseline, urinary hydroxyproline and N-telopeptide were at the upper normal level and decreased only after 24 months of follow-up (p<0.05). During the first year of follow-up, femoral density decreased (p<0.05) and a partial recovery was observed for both spine and femur after 24 months. After 12 months, femoral bone density was negatively associated with serum cyclosporin A levels (p<0.005) and cumulative methylprednisolone intake (p<0.05), while the percent decrease in spinal density after the first 12 months was negatively predicted by mean daily methylprednisolone intake (p<0.05). In patients with pre-transplant cholestatic diseases, femoral and spinal density increased after the first (p<0.05) and second year (p<0.05), respectively. In patients with previous post-necrotic cirrhosis, femoral density decreased after 12 months (p<0.05) and was still lower than baseline after 24 months (p<0.05). However, at the end of the study the cumulative percentage of femoral neck osteoporosis was 43%. In conclusion, an elevated prevalence of spinal and femoral osteoporosis is present even many years after liver transplantation, with immunosuppressive treatment and pre-transplant liver disease being the most important pathogenetic factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 1×
“Corticosteroids affect osteoblast function in several ways [12, 13 ].”
BackgroundEastell, R., Dickson, R. E., Hodgson, S. F., Wiesner, R. H., Porayko, M. K., Wahner, H. W., Cedel, S. L., Riggs, L. B., & Krom, R. A. F. (1991) · Hepatology · doi:10.1002/hep.1840140215 · Cited by 297 · cited 6×
“hepatic function and the resolution of cholestasis after surgery [2, 5 ].”
BackgroundResultInfluentialBone disease after orthotopic liver transplantation
Haagsma, E. B., Thijn, C. J. P., Post, J. G., Slooff, M. J. H., & Gips, C. H. (1988) · Journal of Hepatology · doi:10.1016/s0168-8278(88)80467-7 · Cited by 112 · cited 2×
“Liver transplantationis associatedwith low bonemass and increasedrisk of fractures [1,15].”
Background
Cited by
Guichelaar, M. M. J., Schmoll, J., Malinchoc, M., & Hay, E. J. (2007) · Hepatology · doi:10.1002/hep.21805 · Cited by 120
Guañabens, N., & Parés, A. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.05.030 · Cited by 71
Diagnosis and Management of Cirrhosis-Related Osteoporosis
Santos, L. A. A., & Romeiro, F. G. (2016) · BioMed Research International · doi:10.1155/2016/1423462 · Cited by 66
Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease
Guichelaar, M. M., Malinchoc, M., Sibonga, J. D., Clarke, B. L., & Hay, J. E. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.12.2190 · Cited by 50
“Sixty-three consecutive adult patients who fulfilled the following criteria were enrolled in a randomized controlled trial to test the efficacy of salmon calcitonin therapy (100 iu subcutaneously each day for the first 6 postoperative months) to prevent post-transplant bone loss((17)): (1) advanced primary biliary cir…”
BackgroundMethodTreatment of bone disorders in liver disease
Parés, A., & Guañabens, N. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.06.007 · Cited by 50
“Moreover, most liver transplant patients have a rapid bone loss during the first semester [23,33,38–43], being as high as 6% in the lumbar spine at three months [43], with a progressive and significant increase after one year of followup.”
BackgroundPatel, N., & Muñoz, S. J. (2015) · Clinical Liver Disease · doi:10.1002/cld.498 · Cited by 34
Metadata
- Authors
- Giannini, S., Nobile, M., Ciuffreda, M., Iemmolo, R. M., Dalle Carbonare, L., Minicuci, N., Casagrande, F., Destro, C., Gerunda, G. E., Sartori, L., & Crepaldi, G.
- Venue
- Osteoporosis International
- Published
- 2000-05-01
- Volume
- 11
- Issue
- 5
- Pages
- 417-424
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- OpenAlex
- W2046884305
- Cited by
- 77
- References
- 3
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.